Peter C. Reifsnyder

JCI Insight · 2020

⊕ Open access · CC-BY

Canagliflozin extends life span in genetically heterogeneous male but not female mice

▲ 126

Aging Cell · 2021

⊕ Open access · CC-BY

17‐a‐estradiol late in life extends lifespan in aging UM‐HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex

▲ 114

Aging Cell · 2020

⊕ Open access · CC-BY

Rapamycin‐mediated mouse lifespan extension: Late‐life dosage regimes with sex‐specific effects

▲ 97

Aging Cell · 2022

⊕ Open access · CC-BY

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

▲ 67

GeroScience · 2023

⊕ Open access · CC-BY

Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used

▲ 58

Aging · 2016

⊕ Open access · CC-BY

Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes

▲ 57

GeroScience · 2024

⊕ Preprint · OA

Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin

▲ 31

bioRxiv (Cold Spring Harbor Laboratory) · 2020

⊕ Preprint · OA

Canagliflozin Extends Lifespan in Genetically Heterogeneous Male But Not Female Mice

▲ 12

GeroScience · 2025

⊕ Open access · CC-BY

Extension of lifespan by epicatechin, halofuginone and mitoglitazone in male but not female genetically heterogeneous mice

▲ 6

Genetics · 2025

⊕ Open access · CC-BY

Analysis of lifespan across diversity outbred mouse studies identifies multiple longevity-associated loci

▲ 4

GeroScience · 2025

⊕ Open access · CC-BY

End-of-life pathology in UM-HET3 mice treated with 16 α‑hydroxyestradiol or late‑start canagliflozin

▲ 1